View in EDS

Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b

Saved in:
Bibliographic Details
Title: Health-related quality of life in patients with high-risk melanoma randomised in the Nordic phase 3 trial with adjuvant intermediate-dose interferon alfa-2b
Authors: Brandberg, Y.1 yvonne.brandberg@ki.se, Aamdal, S.2, Bastholt, L.3, Hernberg, M.4, Stierner, U.5, von der Maase, H.6,7, Hansson, J.1
Source: European Journal of Cancer. Sep2012, Vol. 48 Issue 13, p2012-2019. 8p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first